reference/1121253

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/1121253

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't
endingPage	155
issn	0014-2999
issueIdentifier	1-3
pageRange	151-155
publicationName	European Journal of Pharmacology
startingPage	151
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_634e3b5dadc053b60b99fda0b87acb04 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_32b0a1cd7ae99f4ee32fe74686570a89
bibliographicCitation	Yagi H, Yamaguchi N, Shida Y, Hayakawa M, Matsumoto M, Sugimoto M, Wada H, Tsubaki K, Fujimura Y. Cilostazol down-regulates the height of mural platelet thrombi formed under a high-shear rate flow in the absence of ADAMTS13 activity. Eur J Pharmacol. 2012 Sep 15;691(1-3):151–5. doi: 10.1016/j.ejphar.2012.07.001. PMID: 22796451.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a9d76cb6197559aef6de24270a7d9f93 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e3aa814230cd8c4001c7a22e0d286b7d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_55432f4756b3a7c7259a19547da16b2e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4eb7b06a077708b0aae9ca91a3b6b80a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c21abdb8ab92b9fccb1affd4d6f1ede3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_76f01f5de23c43dad98126487e2b2c79 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6a2ce6c8fd8eb62c2f5143dbecafe3c2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cf5c103077765d782819183ef75546e0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4733c4d601789cbd981468b88666417d
date	2012-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1016/j.ejphar.2012.07.001 https://pubmed.ncbi.nlm.nih.gov/22796451
isPartOf	https://portal.issn.org/resource/ISSN/0014-2999 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/3614
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Cilostazol down-regulates the height of mural platelet thrombi formed under a high-shear rate flow in the absence of ADAMTS13 activity
discusses	http://id.nlm.nih.gov/mesh/M0017012 http://id.nlm.nih.gov/mesh/M0004775 http://id.nlm.nih.gov/mesh/M000613168 http://id.nlm.nih.gov/mesh/M0481642 http://id.nlm.nih.gov/mesh/M0021253 http://id.nlm.nih.gov/mesh/M0261423 http://id.nlm.nih.gov/mesh/M0132637
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D013927Q000503 http://id.nlm.nih.gov/mesh/D013777Q000494 http://id.nlm.nih.gov/mesh/D055595 http://id.nlm.nih.gov/mesh/D001792Q000187 http://id.nlm.nih.gov/mesh/D001792Q000502 http://id.nlm.nih.gov/mesh/D010975Q000494 http://id.nlm.nih.gov/mesh/D015536Q000187
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D051722Q000378 http://id.nlm.nih.gov/mesh/D013499 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D000071120 http://id.nlm.nih.gov/mesh/D055815 http://id.nlm.nih.gov/mesh/D003094Q000378 http://id.nlm.nih.gov/mesh/D000077407 http://id.nlm.nih.gov/mesh/D001696 http://id.nlm.nih.gov/mesh/D001760 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D004305 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D010477 http://id.nlm.nih.gov/mesh/D005260
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7065 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7969 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6083 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2754 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_3535f08909368a6421e812f297e6ec30 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9038 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9412 http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_3.1.4.1 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_9b21d1a174c364b6f99c6662d34d6034 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60947 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6076

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129170378 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127654660 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129352801

Total number of triples: 70.